Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0000899243-21-025978

Options or other derivatives

  • Director acquired 6,321,460 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2021-02-24 Grant or award · Series B convertible preferred stock +1,500,000 $2.00 $3,000,000 3,000,000 I: show line 1 in the form
Bolzon Bradley J PhD Director 2021-02-24 Grant or award · Series B convertible preferred stock +2,075,000 $2.00 $4,150,000 4,150,000 I: show line 2 in the form
Bolzon Bradley J PhD Director 2021-03-11 Grant or award · Series C convertible preferred stock +2,699,328 $2.96 $7,999,998 2,699,328 I: show line 3 in the form
Bolzon Bradley J PhD Director 2021-06-23 Grant or award · Stock Option (Right to Buy) +47,132 47,132 D: show line 4 in the form
Loading xslF345X03/doc4.xml…